期刊文献+

辛伐他汀对球囊损伤颈动脉后大鼠血管重塑及血管外膜转化生长因子-β_1表达的影响 被引量:1

Effect of simvastatin on vascular remodeling and TGF-β_1 expression in vascular adventitia in carotids of rats with ballon injury
下载PDF
导出
摘要 目的 探讨辛伐他汀对球囊损伤颈动脉后大鼠血管重塑及血管外膜转化生长因子 β1(TGF β1)表达的影响。方法 将雄性SD大鼠随机分为单纯球囊损伤组 (A组 ,n =18)和球囊损伤 +辛伐他汀干预组 (B组 ,n =18)。A组只进行球囊损伤 ,B组在球囊损伤前 1周至术后 14d应用辛伐他汀。分别于术后 2、7、14d取颈总动脉 ,应用计算机图像分析系统观察血管管腔面积 (LA)、内膜面积 (IA)、内弹力板环绕面积 (IEMA)及血管总面积 (TA)的变化 ,采用免疫组织化学法检测血管外膜TGF β1的表达。结果 球囊损伤后 14d ,B组的LA、IEMA、TA明显扩大 ,IA则减小 ;B组各时间点血管外膜TGF β1的表达明显低于A组 (均P <0 .0 1)。结论 辛伐他汀可以改善球囊损伤后的血管重塑 ,这种作用可能是通过降低血管外膜TGF β1的表达实现的。 Objective To investigate the effects of simvastatin on vascular remodeling and transforming growth factor-β1 (TGF、β1) expression in vascular adventitia in carotid of rats with balloon injury.Methods The male SD rats were randomly divided into ballon injury group (group A,n=18) and the ballon injury group adding simvastatin intervention (group B,n=18). The rats were killed and the carotids were removed at 2,7,14 day after balloon injury respectively.Through image analysis system the change of lumen area(LA),intimal area(IA),intermal elastic lamina area (IEMA) and total vessel area (TA) were observed. We also observed the expression of TGF、β1 in vascular adventitia by the method of routine immunohistochemical staining.Results Compared to group A,IEMA,LA and TA of group B were expanded apparently and IA decreased significantly.The expression of TGF、β1 in group B was much lower than that in group A at anytime(all P<0.01). Conclusions Simvastatin may ameliorate vascular negative remodeling and prevent injury-induced reduction by decreasing the conent of TGF、β1 in vascular adventitia.
出处 《现代医学》 2004年第3期152-155,共4页 Modern Medical Journal
关键词 球囊损伤 血管外膜 辛伐他汀 表达 血管重塑 TGF-β1 转化生长因子-β1 IA 面积 弹力 simvastatin vascular remodeling transforming growth factor-β1 vascular adventitia
  • 相关文献

参考文献9

  • 1SMITH J D, BRYANT S R, COUPER L L, et al. Soluble transforming growth factor-β type Ⅱ receptor inhibit negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth[J]. Cire Res, 1999,84: 1212-1222.
  • 2CHUNG I M, UENO H, PAK Y K, et al. Catheter-based adenovirusmdiated local intravascular gene delivery of a slouble TGF-β type Ⅱ receptor using an infiltrator in porcine coronary arteries: efficacy and complications[J]. Exp Mol Med,2002,34(4):299-307.
  • 3LAFONT A, GUZMAN L A, WBILLOW P L, et al. Restenosis after experimental angioplasty, intimal, medial, and adventitial change associated with constrictive remodeling [ J ]. Circ Res, 1995,76 (6):996-1002.
  • 4SERRUYS P W, de FEYTER P, MACAYA C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention[ J ]. JAMA, 2002,287 (24): 3215-3222.
  • 5SIOW R C, MALLAWAARACHCHI C M, WEISSBERG P L. Migration of adventitial myofibroblasts following vascular balloon injury:insights from in vivo gene transfer to rat carotid arteries[J]. Cardiovasc Res,2003,59( 1 ) :212-221.
  • 6WILCOX J N, OKAMOTO E I, N AKAHARA K I, et al. Perivascular responses after angioplasty which may contribute to postangjoplasty restenosis [ J ]. Ann N Y Acad Sc i, 2001,947 ( 6 ): 68 -90.
  • 7SERINI G, GABBIANI G. Mechanism of myofibroblast activity and phenotypic modulation[J]. Exp Cell Res, 1999;250(2):273-283.
  • 8KINGSTON P A, SINHASS, DAVID A, et al. Adenovirus-mddiated gene transfer of a secreted transforming growth factor-β type Ⅱ recepotor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhance adventitial collagen deposition [ J ].Circulation, 2001,104(21 ) :2535-2601.
  • 9WIERZBICKI A S,POSTON R,FERRO A. The lipid and non-lipid effects of statins[ J]. Pharmacol Ther, 2003,9( 1 ) :95-112.

同被引文献23

  • 1何坪,殷跃辉.阿托伐他汀对血管保护作用的研究进展[J].中国全科医学,2007,10(16):1390-1392. 被引量:33
  • 2Silva EP,Fonseca FA,Ihara SS,et al. Early benefits of pravastatin to experimentally induced atherosclerosis [ J ]. J Cardiovase Pharmacol,2002,39 (3) :389-385.
  • 3Tsunekawa T, Hayashi T, Kano H, et al. Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabe-tic patients within 3 days[ J]. Circulation,2001,104(4) :376- 379.
  • 4Bellosta S, Ferri N, Arnaboldi L, et al. Pleiotropic effects of statins in atherosclerosis and diabetes [ J ]. Diabetes Care, 2000, 23 ( Suppl 2 ) : B72-78.
  • 5Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type III nitricoxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice[ J]. Stroke,2000,31 (10) :2442-2449,.
  • 6Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor X III and by enhancing factor Va inactivation [ J ]. Circulation, 2001,103 ( 18 ) : 2248-2253.
  • 7Poli A. Atorvastatin: pharmacological characteristics and lipid-lowering effects[ J]. Drugs,2007,67 ( Suppl 1 ) :3-15.
  • 8Rubba P. Effects of atorvastatin on the different phases of atherogenesis [ J ]. Drags,2007,67 ( Suppl 1 ) : 17-27.
  • 9Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling[ J]. N Engl J Med,1994,330(20) :1431-1438.
  • 10Su SF, Hsiao CL, Chu CW, et al. Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension[ J]. Am J Cardiol,2000,86(5) :514-518.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部